Asset Management Group, Inc. Pfizer Inc Transaction History

Asset Management Group, Inc.

$537 Million
Q1 2025

A detailed history of Asset Management Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Asset Management Group, Inc. holds 44,838 shares of PFE stock, worth $1.09 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

44,838

Previous 46,637 3.86%

Holding current value

$1.09 Million

Previous $1.24 Million 8.16%

% of portfolio

0.21%

Previous 0.18%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$25.01 - $27.13 $44,992 - $48,806	-1,799 Reduced 3.86%	44,838 $1.14 Million
Q4 2024 Feb 14, 2025	SELL	$24.8 - $30.19 $129,976 - $158,225	-5,241 Reduced 10.1%	46,637 $1.24 Million
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $24,237 - $27,466	875 Added 1.72%	51,878 $1.5 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $17,252 - $20,216	683 Added 1.36%	51,003 $1.43 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $19,158 - $22,000	740 Added 1.49%	50,320 $1.4 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $18,160 - $23,588	-695 Reduced 1.38%	49,580 $1.43 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $40,658 - $47,525	-1,267 Reduced 2.46%	50,275 $1.67 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $3,684 - $4,262	-102 Reduced 0.2%	51,542 $1.89 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $7,996 - $10,409	203 Added 0.39%	51,644 $2.11 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $15,656 - $20,437	375 Added 0.73%	51,441 $2.64 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $17,766 - $21,688	406 Added 0.8%	51,066 $2.24 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $17,774 - $21,074	382 Added 0.76%	50,660 $2.66 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $17,339 - $21,485	379 Added 0.76%	50,278 $2.6 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $9,007 - $13,352	218 Added 0.44%	49,899 $2.95 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $186,987 - $240,200	4,764 Added 10.61%	49,681 $2.14 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $14,399 - $16,312	401 Added 0.9%	44,917 $1.76 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $15,103 - $17,034	451 Added 1.02%	44,516 $1.61 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $12,383 - $15,747	370 Added 0.85%	44,065 $1.62 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $12,795 - $15,011	403 Added 0.93%	43,695 $1.6 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $72,800 - $88,317	2,417 Added 5.91%	43,292 $1.42 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $7,217 - $10,311	-267 Reduced 0.65%	40,875 $1.33 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $10,962 - $12,440	333 Added 0.82%	41,142 $1.61 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $23,945 - $31,049	-737 Reduced 1.77%	40,809 $1.47 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $114,896 - $129,002	-3,107 Reduced 6.96%	41,546 $1.8 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $12,187 - $13,390	325 Added 0.73%	44,653 $1.9 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $280,292 - $319,563	7,286 Added 19.67%	44,328 $1.94 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $8,927 - $10,828	259 Added 0.7%	37,042 $1.63 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $2,044 - $2,179	-62 Reduced 0.17%	36,783 $1.34 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $8,902 - $10,328	279 Added 0.76%	36,845 $1.31 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $36,153 - $38,360	-1,087 Reduced 2.89%	36,566 $1.32 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $1.17 Million - $1.29 Million	37,653	37,653 $1.34 Million

Others Institutions Holding PFE

# of Institutions

3,321

Shares Held

3.65B

Call Options Held

103M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $136B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management Group, Inc. with notifications on news.

Account

Asset Management Group, Inc. Pfizer Inc Transaction History